<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04909190</url>
  </required_header>
  <id_info>
    <org_study_id>SF2021</org_study_id>
    <nct_id>NCT04909190</nct_id>
  </id_info>
  <brief_title>Increased Saline Flush to Reduce the Amount of Residual Air Inside a Stentgraft Delivery System</brief_title>
  <official_title>A Randomized Trial of an Increased Saline Flush Protocol to Reduce the Amount of Residual Air Inside a Stentgraft Delivery System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-randomized studies have shown that de-airing of the delivery system with an increased&#xD;
      volume of saline may be associated to a decrease in periprocedural stroke during thoracic&#xD;
      endovascular aortic repair. This study is designed to provide evidence that 4xIFU-dose volume&#xD;
      of saline flush vs. standard IFU-dose saline flush is associated to a decrease in the amount&#xD;
      of intra-sac air detected on the first follow-up imaging after EVAR.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Air volume</measure>
    <time_frame>within 7 days after index procedure</time_frame>
    <description>Total volume of air inside the aneurysm sac on discharge CT imaging.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aortic Aneurysm</condition>
  <condition>Aortic Aneurysm, Thoracic</condition>
  <condition>Aortic Diseases</condition>
  <condition>Aortic Arch Aneurysm</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>1xIFU</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects in this arm are randomized to have a saline flush volume according to the IFU of the used device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4xIFU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm are randomized to have a saline flush volume of 4x of what is stated in the IFU of the used device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Increased saline flush volume</intervention_name>
    <description>Additional flushing of the stentgraft delivery system.</description>
    <arm_group_label>4xIFU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  endovascular aortic repair of an abdominal aortic aneurysm using either of these&#xD;
             devices: Terumo/Bolton Treo, Terumo Anaconda, Cook Zenith Alpha Abdominal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  concomitant use of an iliac bifurcation device due to insufficient common iliac&#xD;
             landing zone on either side&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Csaba Csobay-Novák, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Interventional Radiology, Heart and Vascular Center, Semmelweis University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Csaba Csobay-Novák, MD PhD</last_name>
    <phone>+36208258118</phone>
    <email>csobay.csaba@med.semmelweis-univ.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarolta Borzsák, MD</last_name>
    <phone>+36206663461</phone>
    <email>borzsak.sarolta@med.semmelweis-univ.hu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Csaba Csobay-Novák, MD PhD</last_name>
      <phone>+36208258118</phone>
      <email>csobay.csaba@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Sarolta Borzsák, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>András Szentiványi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endovascular</keyword>
  <keyword>evar</keyword>
  <keyword>tevar</keyword>
  <keyword>stentgraft</keyword>
  <keyword>de-airing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Diseases</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

